News
-
-
-
COMMUNIQUÉ DE PRESSE
Catheter Precision, Inc. (NYSE American: VTAK) Reports Preliminary Unaudited Revenue for the Second Quarter and Six Months Ended June 30, 2024
Catheter Precision, Inc. reports 15% quarter-over-quarter growth with initial sales of LockeT recorded, generating total revenue of $94,840 for Q2 ending June 30, 2024 -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Catheter Precision, Inc. Announces Receipt of LockeT Purchase Order for Eisenhower Medical Center, a Third California Hospital
Catheter Precision, Inc. announces new purchase order for LockeT, a suture retention device. The US-based medical device company focuses on electrophysiology products -
